YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ajanta Pharma
Ajanta Pharma
BSE: 532331NSE: AJANTPHARMISIN: INE031B01049

30th-Apr-2021 16:31Source: BSE

Ajanta Pharma - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

This is to inform you that Ajanta Pharma Limited has subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP).

The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Clause A(1) of Part A, Schedule III of the aforesaid regulations, is attached as per 'Annexure A'.

Sections